Home » Topics » Regulatory

Regulatory
RSS

Eisai launches new formulation of antiarrhythmic drug in Japan

Dec. 16, 1998

FDA approves expanded indication for CytoGam

Dec. 14, 1998

Philippines is the first market for lamivudine as anti-HBV agent

Dec. 14, 1998

Schering-Plough files NDA for next-generation corticosteroid

Dec. 14, 1998

FDA approves Rebetron combination therapy for previously untreated HCV patients

Dec. 11, 1998

FDA approves Sandostatin LAR once-monthly depot formulation

Dec. 7, 1998

Canadian approval obtained for Serostim

Dec. 4, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

FDA approves Verelan PM; launch scheduled for early 1999

Dec. 4, 1998

Genzyme General receives FDA approval for Thyrogen

Dec. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...